In 2014, the World Health Organization approved Resolution WHA67.9 on Psoriasis. This Resolution officially acknowledged psoriasis as a non-communicable disease (NCD). Two years later, the WHO published a follow-up Global Report on Psoriasis, including a range of recommendations on what the world can do to improve living conditions for people with psoriasis.
Now, IFPA wants to make sure these recommendations are acted upon. We want to highlight psoriasis as a severe NCD. Simply said, we want to take the next step.
That is why we have created the Global Psoriasis Coalition.
Our plans for the Global Psoriasis Coalition
Policy-wise, the international community already does a great deal to address major NCDs like diabetes or heart disease. The WHO, for example, has a comprehensive “Global Action Plan for the Prevention and Control of NCDs 2013-2020.” This is great: all patients deserve better living conditions. However, in the current version of the Global Action Plan, psoriasis is nowhere to be seen.
This needs to change.
Psoriasis should be included in the Global Action Plan not just because it affects over 125 million people worldwide, but also because there appears to be a strong link between psoriasis and other NCDs like diabetes and heart disease. That means working to detect psoriasis early on can prevent and help control other NCDs too.
In 2018 and 2020, the WHO Global Action Plan will be revised. The Global Psoriasis Coalition will be advocating to prioritize psoriasis during these revisions, as this will strengthen the prevention and control of other NCDs. Getting psoriasis included in the revised WHO Global Action Plan is also the best way of making sure the WHO Resolution and Global Report are implemented.
Like the sound of the Global Psoriasis Coalition? We do too – and we can’t wait to give you more information!
More details on the Coalition will be published soon, but if you have a pressing question in the meantime, feel free to contact us.